/ NKTR

Why Is Nektar (NKTR) Stock Up 17% Premarket Today? Positive AD Trial Data
/ Market Analysis

Why Is Nektar (NKTR) Stock Up 17% Premarket Today? Positive AD Trial Data

Nektar stock jumped more than 17% in premarket trading after the company reported positive 52-week data from its REZOLVE-AD atopic dermatitis trial.

February 10, 2026
Nektar Therapeutics (NKTR) Jumps 116% in Premarket After Positive Trial Results

Nektar Therapeutics (NKTR) Jumps 116% in Premarket After Positive Trial Results

Nektar Therapeutics stock surged 116% in premarket trading after announcing successful Phase 2b trial results for its atopic dermatitis treatment.

June 24, 2025

Trending

Why Is Nvidia Stock Higher Premarket? China Approves AI Chip Sales
Why Is Nvidia Stock Higher Premarket? China Approves AI Chip Sales
March 18, 2026
AMD Stock Rises Premarket Today as Samsung Partnership Expands
AMD Stock Rises Premarket Today as Samsung Partnership Expands
March 18, 2026
Why Is Qualcomm (QCOM) Stock Moving Higher Today? $20B Buyback Plan
Why Is Qualcomm (QCOM) Stock Moving Higher Today? $20B Buyback Plan
March 17, 2026
Academy Sports (ASO) Falls Short on Q4 Earnings and Revenue, Stock Drops
Academy Sports (ASO) Falls Short on Q4 Earnings and Revenue, Stock Drops
March 17, 2026